The Global Neurological Movement Disorders Market has been estimated to reach a value of USD 12,800 million in 2021 and is projected to reach USD XX million by 2030, at a CAGR of 9.80% during the forecast period.
Medically, neurological diseases are disorders that affect the brain as well as the nerves located in the human body and the spinal cord. A variety of symptoms may be caused by structural, biochemical, or electrical abnormalities in the brain, spinal cord, or other nerves due to neurological diseases.
The neurological movement disorder is a condition that causes abnormal increased movements, which may be voluntary or involuntary. Movement disorders can also cause reduced or slow movements. The lack of dopamine, a brain chemical, generated by nerve cells in the brain results in mental disturbances and uncoordinated movements in people.
The primary growth drivers for the neurological movement disorders market are the introduction of efficient and advanced technology, the growing prevalence of neurodegenerative disorders, patent expiration of many blockbuster drugs, and the emergence of new technologies.
FIGURE 1: GLOBAL NEUROLOGICAL MOVEMENT DISORDERS MARKET
Furthermore, increased incidence of movement disorders in emerging economies such as China, India, and others would create new opportunities for research and development activities in the global neurological movement disorder market. The prevalence of neurological disorders such as multiple sclerosis (MSA), Parkinson's disease, and Huntington's disease is expected to drive growth of the global movement disorders market in the coming years.
Improving economies and health in developing countries such as China and India have increased life expectancy and shifted the focus away from communicable diseases to non-communicable diseases. This is expected to increase the focus on movement disorders and age-related diseases such as Parkinson's disease.
Neurological movement disorders can impair the ability to walk, speak, and move. Living with a progressive movement disorder, such as Parkinson's disease, can make daily activities difficult. According to a publication of the Neurological Society of India, movement disorders constitute 3-8% of neurological disorders in India, with a crude prevalence rate (CPR) varying from 31 to 45/100,000 above 60 years of age. They are more frequent in rural India.
The global neurological movement disorders market has been segmented by disorder type, treatment type, end user, and region.
FIGURE 2: GLOBAL NEUROLOGICAL MOVEMENT DISORDERS SEGMENTATION
Global Neurological Movement Disorders Market, By Disorder Type
Based on the disorder type, the market is segmented into ataxia, chorea, dystonia, functional movement disorder, Huntington’s disease, multiple system atrophy, myoclonus, Parkinson’s disease, and others. Among these, the Parkinson’s disease segment is projected to dominate the market during the forecast period.
Parkinson's disease (PD) is a progressive neurological condition that affects body movements. It has five stages which can affect an individual's facial expressions and hand and leg gestures as they get older. The mean onset age for Parkinson's disease is the early 60’s, though 5-10% have onset before the age of 40 years. Life expectancy is also reduced in Parkinson's disease. According to Parkinson’s Foundation, approximately 60,000 Americans are diagnosed with PD each year.
Huntington's disease (HD) is an inherited neurodegenerative disorder that causes a variety of motor, cognitive, and psychiatric symptoms. According to National Organization for Rare Disorders, about 30,000 people in the United States have Huntington's disease and another 200,000 are at risk of developing the condition.
Global Neurological Movement Disorders Market, By Treatment Type
Based on the treatment type, the market is segmented into drugs, deep brain stimulation, and non-invasive treatments . Deep brain stimulation is further segmented into fixed-life, rechargeable battery. In many cases, movement disorders cannot be cured, and the goal of treatment is to minimize symptoms and relieve pain. Drug therapies are to control symptoms of movement disorder. Deep brain stimulation basically uses an implant to stimulate the areas of the brain that controls movements.
Global Neurological Movement Disorders Market, By End User
Based on end user, the market is segmented into hospital, clinics & ablation centers, ambulatory surgical centers, and research laboratories & academic institutes. Among these, the hospital segment is anticipated to dominate the market. Hospitals are an essential component of healthcare systems around the world. It is the first point-of-care for patients that offers access to superior care, sets expectations, and provides better services to the nation's health system as a whole.
Global Neurological Movement Disorders Market, By Region
Based on region, the market is segmented as North America, Europe, Asia Pacific, the Middle East & Africa, and South America. North America is expected to dominate the market during the forecast period. Increased awareness about the disorder, combined with the growing prevalence of diseases restricting movement, is expected to promote regional market growth in the coming years.
FIGURE 3: GLOBAL NEUROLOGICAL MOVEMENT DISORDERS MARKET OVERVIEW (USD MILLION)
What does this Report Provide?
A detailed understanding of the global neurological movement disorders market demand from a qualitative and quantitative perspective. The report also provides dynamic indicators with potential impact on the market during the forecast period and an in-depth analysis of the leading companies operating in the global neurological movement disorders market.
The major market drivers, challenges, and opportunities for the market have also been covered in the report. This report includes the market shares of the leading companies, their production capacities, and the growth strategies adopted by them.
Some Recent Developments in the Global Neurological Movement Disorders Market
- January 2020 - Abbott received expanded indication from the U.S. FDA for directional deep brain stimulation system to treat Parkinson's disease.
Neurological Movement Disorders Market Segmentation:
By Disorder Type
- Functional Movement Disorder
- Huntington’s Disease
- Multiple System Atrophy
- Parkinson’s Disease
By Treatment Type
- Deep Brain Stimulation
- Rechargeable Battery
- Non Invasive Treatments
By End User
- Hospital, Clinics, & Ablation Centers
- Ambulatory Surgical Centers
- Research Laboratories & Academic Institutes
North America Neurological Movement Disorders Market
- North America, by Country
- North America, by Disorder Type
- North America, by Treatment Type
- North America, by End User
Europe Neurological Movement Disorders Market
- The Rest of Europe
- Europe, by Disorder Type
- Europe, by Treatment Type
- Europe, by End User
Asia Pacific Neurological Movement Disorders Market
- South Korea
- The Rest of Asia Pacific
- Asia Pacific, by Disorder Type
- Asia Pacific, by Treatment Type
- Asia Pacific, by End User
The Middle East and Africa Neurological Movement Disorders Market
- Middle East and Africa, by Country
- Saudi Arabia
- South Africa
- The Rest of Middle East and Africa
- Middle East and Africa, by Disorder Type
- Middle East and Africa, by Treatment Type
- Middle East and Africa, by End User
South America Neurological Movement Disorders Market
- South America, by Country
- The Rest of South America
- South America, by Disorder Type
- South America, by Treatment Type
- South America, by End User
Major Companies: In this report, the following major companies are studied: Abbott Laboratories,Inc., Boston Scientific Corporation, Aleva Neurotherapeutics Sa, Nexstim, Neuropace, Inc., Allergan, EISAI Co., Ltd, IPSEN, Insightec Ltd, Merz Pharma, Abbvie, Sonacare Medical, and Resofus Alomar.
Objectives of This Report:
- To estimate the neurological movement disorders market size on a regional and global basis
- To identify major segments in the neurological movement disorders market and evaluate their market shares and demand
- To provide a competitive scenario for the neurological movement disorders market with major developments observed by key companies in the historic years
- To evaluate key factors governing the dynamics of neurological movement disorders market with their potential gravity during the forecast period
- To evaluate the leading company-wise pricing analysis for the mentioned applications
This study is customized to meet your specific requirements:
- By sub-segment
- By client-specific country, type, and application market analysis
- Pricing analysis along with the potential list of customers
- Product-specific competitive analysis
For more information, contact: [email protected]